Velphoro® (Polynuclear Iron (III)-Oxyhydroxide, Sucroferric Oxyhydroxide)
Velphoro® is a non-calcium, iron based chewable phosphate binder for the control of serum phosphorus levels in adult patients with Chronic Kidney Disease (CKD) on dialysis treatment (haemodialysis or peritoneal dialysis). The recommended starting dose of Velphoro® is 3 tablets per day (1 tablet per meal), and Velphoro® could therefore help to improve phosphate management in these patients. Velphoro® was developed by Vifor Pharma and is produced in Switzerland. The rights of Velphoro® are with Vifor Fresenius Medical Care Renal Pharma. Depending on the country the distribution is done through either Vifor Pharma or Fresenius Medical Care.
For more information please visit www.velphoro.com.